162 related articles for article (PubMed ID: 29861579)
1. Association of Diopsys® Short-duration Transient Visual Evoked Potential Latency with Visual Field Progression in Chronic Glaucoma.
Trevino R; Sponsel WE; Majcher CE; Allen J; Rabin J
J Curr Glaucoma Pract; 2018; 12(1):29-35. PubMed ID: 29861579
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of short-duration transient visual evoked potentials (SD-tVEP) in discriminating normal from glaucomatous eyes.
Pillai C; Ritch R; Derr P; Gonzalez A; Kopko Cox L; Siegfried J; Liebmann JM; Tello C
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2847-52. PubMed ID: 23513061
[TBL] [Abstract][Full Text] [Related]
3. Short duration transient visual evoked potentials in glaucomatous eyes.
Prata TS; Lima VC; De Moraes CG; Trubnik V; Derr P; Liebmann JM; Ritch R; Tello C
J Glaucoma; 2012 Aug; 21(6):415-20. PubMed ID: 21562431
[TBL] [Abstract][Full Text] [Related]
4. Prospective Comparison of VisuALL Virtual Reality Perimetry and Humphrey Automated Perimetry in Glaucoma.
Griffin JM; Slagle GT; Vu TA; Eis A; Sponsel WE
J Curr Glaucoma Pract; 2024; 18(1):4-9. PubMed ID: 38585168
[TBL] [Abstract][Full Text] [Related]
5. Repeatability of short-duration transient visual evoked potentials in normal subjects.
Tello C; De Moraes CG; Prata TS; Derr P; Patel J; Siegfried J; Liebmann JM; Ritch R
Doc Ophthalmol; 2010 Jun; 120(3):219-28. PubMed ID: 20111979
[TBL] [Abstract][Full Text] [Related]
6. Pattern Electroretinography and Visual Evoked Potentials Provide Clinical Evidence of CNS Modulation of High- and Low-Contrast VEP Latency in Glaucoma.
Sponsel WE; Johnson SL; Trevino R; Gonzalez A; Groth SL; Majcher C; Fulton DC; Reilly MA
Transl Vis Sci Technol; 2017; 6(6):6. PubMed ID: 29134137
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of VEP perimetry in normal subjects and glaucoma patients.
Bengtsson B
Acta Ophthalmol Scand; 2002 Dec; 80(6):620-6. PubMed ID: 12485283
[TBL] [Abstract][Full Text] [Related]
8. Detecting Glaucoma Progression Using Guided Progression Analysis with OCT and Visual Field Assessment in Eyes Classified by International Classification of Disease Severity Codes.
Nguyen AT; Greenfield DS; Bhakta AS; Lee J; Feuer WJ
Ophthalmol Glaucoma; 2019; 2(1):36-46. PubMed ID: 32672556
[TBL] [Abstract][Full Text] [Related]
9. Visual evoked potential repeatability using the Diopsys NOVA LX fixed protocol in normal older adults.
Trevino RC; Majcher CE; Henry AM; Rodriguez M; Sponsel WE
Clin Ophthalmol; 2018; 12():1713-1729. PubMed ID: 30233135
[TBL] [Abstract][Full Text] [Related]
10. Short-duration transient visual evoked potentials and color reflectivity discretization analysis in glaucoma patients and suspects.
Waisbourd M; Gensure RH; Aminlari A; Shah SB; Khanna N; Sood N; Molineaux J; Gonzalez A; Myers JS; Katz LJ
Int J Ophthalmol; 2017; 10(2):254-261. PubMed ID: 28251085
[TBL] [Abstract][Full Text] [Related]
11. Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study.
Yu M; Lin C; Weinreb RN; Lai G; Chiu V; Leung CK
Ophthalmology; 2016 Jun; 123(6):1201-10. PubMed ID: 27001534
[TBL] [Abstract][Full Text] [Related]
12. SHORT TERM EVALUATION OF PERIMETRIC PROGRESSION IN PATIENTS WITH OPEN ANGLE GLAUCOMA AND DIABETES.
Pantalon A; Feraru C; Chiseliţa D
Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):83-9. PubMed ID: 27125077
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
[TBL] [Abstract][Full Text] [Related]
14. Validating tablet perimetry against standard Humphrey Visual Field Analyzer for glaucoma screening in Indian population.
Ichhpujani P; Thakur S; Sahi RK; Kumar S
Indian J Ophthalmol; 2021 Jan; 69(1):87-91. PubMed ID: 33323582
[TBL] [Abstract][Full Text] [Related]
15. Objective VEP perimetry in glaucoma: asymmetry analysis to identify early deficits.
Graham SL; Klistorner AI; Grigg JR; Billson FA
J Glaucoma; 2000 Feb; 9(1):10-9. PubMed ID: 10708226
[TBL] [Abstract][Full Text] [Related]
16. [The association between corneal biomechanical parameters and visual field progression in patients with normal tension glaucoma].
Li BB; Cai Y; Pan YZ; Li M; Fang Y; Tian T; Yan XM
Zhonghua Yan Ke Za Zhi; 2018 Mar; 54(3):171-176. PubMed ID: 29518874
[No Abstract] [Full Text] [Related]
17. Oculokinetic perimetry compared with Humphrey visual field analysis in the detection of glaucomatous visual field loss.
Wishart PK
Eye (Lond); 1993; 7 ( Pt 1)():113-21. PubMed ID: 8325400
[TBL] [Abstract][Full Text] [Related]
18. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
[TBL] [Abstract][Full Text] [Related]
19. Multifocal objective perimetry in the detection of glaucomatous field loss.
Goldberg I; Graham SL; Klistorner AI
Am J Ophthalmol; 2002 Jan; 133(1):29-39. PubMed ID: 11755837
[TBL] [Abstract][Full Text] [Related]
20. Central 10-degree visual field change following non-penetrating deep sclerectomy in severe and end-stage glaucoma: preliminary results.
Leleu I; Penaud B; Blumen-Ohana E; Rodallec T; Adam R; Laplace O; Akesbi J; Nordmann JP
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1489-1498. PubMed ID: 29862428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
